Longeveron Shares 2011-2026 | LGVN

Annual Shares Longeveron

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.41 B	2.17 B	21 M	18.9 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.41 B	18.9 M	2.91 B

Quarterly Shares Longeveron

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
18.4 B	15 B	15 B	13.6 B	6.51 B	2.51 B	2.12 B	2.11 M	2.1 M	-	21 M	20.9 M	20.9 M	-	19.1 M	19 M	17.5 B	-	16 M	16 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18.4 B	2.1 M	5.34 B

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Xeris Pharmaceuticals XERS	160 M	$ 6.03	-1.55 %	$ 885 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
UroGen Pharma Ltd. URGN	48.1 M	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	57.5 M	$ 10.89	-30.36 %	$ 530 M	Niderland
GT Biopharma GTBP	5.51 M	$ 0.47	-2.41 %	$ 892 K	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	299 M	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	6.18 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	358 K	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	58 M	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	91.5 M	-	-	-	Russia
Фармсинтез LIFE	301 M	-	-	-	Russia
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	103 M	$ 2.19	-9.77 %	$ 226 M	USA
Entera Bio Ltd. ENTX	18.4 M	$ 1.38	-0.72 %	$ 63.3 M	Israel
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	17.9 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	71 M	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	5.59 M	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	5.01 M	-	4.14 %	$ 49.1 M	USA
Evogene Ltd. EVGN	40.4 M	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	12.3 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	415 M	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	1.77 B	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	62.9 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	48.1 M	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	5.45 M	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	126 M	$ 20.67	-1.38 %	$ 2.61 B	USA